These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15231665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Domains involved in ETO and human N-CoR interaction and ETO transcription repression.
    Wang J, Wang M, Liu JM.
    Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542
    [Abstract] [Full Text] [Related]

  • 3. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
    Kohzaki H, Ito K, Huang G, Wee HJ, Murakami Y, Ito Y.
    Oncogene; 1999 Jul 15; 18(28):4055-62. PubMed ID: 10435586
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
    Choi Y, Elagib KE, Delehanty LL, Goldfarb AN.
    Cancer Res; 2006 Mar 15; 66(6):2990-6. PubMed ID: 16540647
    [Abstract] [Full Text] [Related]

  • 11. A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1.
    Harada Y, Harada H, Downing JR, Kimura A.
    Biochem Biophys Res Commun; 2001 Jun 15; 284(3):714-22. PubMed ID: 11396961
    [Abstract] [Full Text] [Related]

  • 12. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.
    Lindberg SR, Olsson A, Persson AM, Olsson I.
    Exp Hematol; 2005 Feb 15; 33(2):189-98. PubMed ID: 15676213
    [Abstract] [Full Text] [Related]

  • 13. AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain.
    Wei H, Liu X, Xiong X, Wang Y, Rao Q, Wang M, Wang J.
    FEBS Lett; 2008 Jun 25; 582(15):2167-72. PubMed ID: 18519037
    [Abstract] [Full Text] [Related]

  • 14. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC, Sun X, Berguido FJ, Jakubowiak A, Nimer SD.
    Oncogene; 1999 Mar 04; 18(9):1701-10. PubMed ID: 10208431
    [Abstract] [Full Text] [Related]

  • 15. Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.
    Tonks A, Tonks AJ, Pearn L, Pearce L, Hoy T, Couzens S, Fisher J, Burnett AK, Darley RL.
    Leukemia; 2004 Jul 04; 18(7):1238-45. PubMed ID: 15152269
    [Abstract] [Full Text] [Related]

  • 16. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S, Hoogeveen AT, Liang P, Stanciu C, van der Spek P, Sacchi N.
    BMC Genomics; 2007 Feb 01; 8():38. PubMed ID: 17266773
    [Abstract] [Full Text] [Related]

  • 17. Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation.
    Rossetti S, Van Unen L, Touw IP, Hoogeveen AT, Sacchi N.
    Oncogene; 2005 Aug 11; 24(34):5325-32. PubMed ID: 16007222
    [Abstract] [Full Text] [Related]

  • 18. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
    Nimer SD, Moore MA.
    Oncogene; 2004 May 24; 23(24):4249-54. PubMed ID: 15156180
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
    Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD.
    Oncogene; 1995 Dec 21; 11(12):2667-74. PubMed ID: 8545124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.